药物设计中的生物核磁共振技术
中国药科大学学报2004 Vol.35 No.5 P.387-392
核磁共振技术在方法学和硬件上的迅速发展,使其成为化学和结构生物学中最重要的波谱技术.特别是生物核磁共振技术在药物研发过程中,提供从药物设计结构信息到基于NMR技术进行配体的筛选的广泛应用,使得生物核磁共振技术在药物研究领域地位不断加强,成为药物研究的基础工具.本文综述了生物核磁共振技术在药物设计中的方法与应用
参考文献:
[1]Shuker SB,Hajduk PJ,Meadows RP,et al.Discovering high-affinity ligands for proteins:SAR by NMR[J].Science,1996,274(5292):1531-1536.
[2]Gargaro AR,Soteriou A,Frenkiel TA,et al.The solution structure of the complex of Lactobacillus casei dihydrofolate reductase with methotrexate[J].J Mol Biol,1998,277(1):119-134.
[3]Wlodawer A,Vondrasek J.Inhibitors of HIV-1 protease:a major success of structre-assisted drug design[J].Annu Rev Biophys Biomol Struct,1998,27:249-284.
[4]Stockmana BJ,Dalvit C.NMR screening techniques in drug discovery and drug design[J].Progress in Nuclear Magnetic Resonance Spectroscopy,2002,41:187-231.
[5]Bjerring M,Vosegaard T,Malmendal A,et al.Methodological development of solid-state NMR for characterization of membrane proteins[J].Concepts in Magnetic Resonance Part A,2003,18A(2):111-129.
[6]Bak M,Schultz R,Nielsen NC.Numerical simulations for experiment design and extraction of structural parameters in biological solid-state NMR spectroscopy.In:Kiihne SR,de Groot HJM,eds.Perspectives on Solid-State NMR in Biology.Dordrecht.Holland:Kluwer Academic Publishers,2001.95-109.
[7]Pochapsky SS,Pochapsky TC.Nuclear magnetic resonance as a tool in drug discovery,metabolism and disposition[J].Current Topics in Medicinal Chemistry,2001,1(5):427-441.
[8]Jardetzky O.Protein dynamics and conformational transitions in allosteric proteins[J].Prog Biophys Mol Biol,1996,65(3):171-218.
[9]Nieto PM,Birdsall B,Morgan WD.Frenkiel TA:correlated bond rotations in interactions of arginine residues with ligand carboxylate groups in protein ligand complexes[J].FEBS Lett,1977,405(1):16-20.
[10]Mark G,Echols N.Exploring the range of protein flexibility,from a structural proteomics perspective[J].Current Opinion in Chemical Biology,2004,8(1):14-19.
[11]Kay LE.Correlation between binding and dynamics at SH2 domain interfaces[J].Nat Struct Boil,1998,5:156-163.
[12]Ben Davis1,Mohammad Afshar1,Gabriele Varani.Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots"[J].J Mol Biol,2004,336(2):343-356.
[13]Gordon CK,Roberts.Applications of NMR in drug discovery[J].DDT,2000,5(6):230-240.
[14]Murray Coles,Heller M,Kessler H.NMR-based screening technologies[J].DDT,2003,8(17):803-810.
[15]Christopher A.Lepre,library design for NMR-based screening[J].DDT,2001,6(3):133-140.
[16]Maria van Dongen,Weigelt J.Structure-based screening and design in drug discovery[J].DDT,2002,7(8):471-478.